New hope pill tested for kids with Tough-to-Treat cancers
NCT ID NCT04299191
Summary
This study is testing a new oral medication called LAM561 for children under 18 with advanced, hard-to-treat cancers, including aggressive brain tumors. The main goals are to find a safe daily dose and see how well the body handles the drug. If the treatment shows benefit, children may have the option to continue taking it after the study ends.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH GRADE GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arkansas Children's Research Institute
RECRUITINGLittle Rock, Arkansas, 72202, United States
Contact Email: •••••@•••••
Contact
-
Hackensack Meridian Health, Inc
RECRUITINGEdison, New Jersey, 08837, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Miami Hospital
RECRUITINGMiami, Florida, 33146, United States
Contact
Conditions
Explore the condition pages connected to this study.